Hologic (HOLX) Akcia Kurs
Hologic Kurs
Za posledných 19 rokov vzrástli tržby Hologic o 12,2 % ročne a dosiahli 4,10 Miliarda USD. Zisk na akciu rástol o 12,8 % ročne za posledných 19 rokov. Pri Hologic je čistá marža 13,8 % klesla oproti 33,2 % pred niekoľkými rokmi. Konsenzuálna 12-mesačná cieľová cena pre Hologic je 77,52 USD, asi nad cenu o 2,0 %. Z 23 analytikov 0 odporúča nákup — celkový konsenzus je Držať.
Cena akcie Hologic
Tieto dáta cez Eulerpool API
100 000 požiadaviek/mes. zadarmo · bez karty
Akcia Hologic a analýza akcií
Často kladené otázky o akcii Hologic
The main competitors of Hologic Inc in the market include companies like Abbott Laboratories, Thermo Fisher Scientific, and Becton, Dickinson and Company.
The business model of Hologic Inc revolves around providing innovative diagnostic solutions, primarily focused on women's healthcare. Hologic develops and markets a wide range of medical devices and instruments, including imaging systems, surgical products, and molecular diagnostic assays. The company's products are designed to enable healthcare professionals to effectively screen, diagnose, and treat various conditions and diseases. Hologic is renowned for its advanced technologies in breast health, gynecology, and skeletal health, offering solutions that empower early detection and intervention. By constantly pushing the boundaries of medical technology, Hologic Inc remains committed to improving healthcare outcomes for women around the world.
Hologic Inc is primarily active in the healthcare industry, specifically in the field of diagnostic products and medical devices. With a focus on improving women's health, Hologic Inc develops and manufactures a wide range of innovative solutions. Their portfolio includes advanced imaging systems, molecular diagnostic assays, surgical instruments, and women's health screening tests. As a prominent player in the healthcare sector, Hologic Inc constantly strives to provide cutting-edge technologies and solutions to address various medical challenges.
Hologic Inc is a leading global healthcare and diagnostics company. Established in 1985, Hologic has excelled in providing innovative solutions for women's health, with a focus on early detection and treatment of breast and cervical cancers. The company's dedication to research and development has resulted in breakthrough technologies, including the introduction of the first 3D mammography system. Hologic has expanded its portfolio to include diagnostics, surgical and skeletal health, and GYN surgical products. With a strong commitment to advancing healthcare, Hologic Inc continues to make significant contributions to improving patient outcomes and quality of life.
Hologic Inc, a leading healthcare company, has achieved several significant milestones. In recent years, the company has made notable advancements in breast health solutions. They introduced the world's first 3D mammography system, which revolutionized breast cancer detection by providing clearer and more accurate images. Hologic Inc also developed the Genius™ 3D Mammography™ exam, proven to detect breast cancer at an earlier stage compared to 2D mammography alone. Furthermore, the company expanded its portfolio by acquiring Gen-Probe, a molecular diagnostics company, allowing Hologic Inc to offer a comprehensive range of diagnostic solutions. These milestones highlight Hologic Inc's commitment to innovation and improving women's healthcare outcomes.
Hologic Inc is primarily present in various countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered. Additionally, Hologic Inc operates in Europe, including countries like Germany, France, Italy, and the United Kingdom. It also has a presence in Asia, particularly in countries such as China and Japan. Furthermore, Hologic Inc serves customers in Canada and Latin America, with a focus on countries like Mexico and Brazil. Overall, Hologic Inc has a global reach and aims to provide its products and services to diverse markets internationally.
Hologic Inc represents values of innovation, commitment to quality, and patient-centric approach. The corporate philosophy of Hologic Inc revolves around developing cutting-edge medical technologies to improve women's health outcomes. With a focus on providing accurate and reliable diagnostic solutions, Hologic Inc strives to empower healthcare professionals and patients alike. The company's dedication to research and development, evidence-based practices, and collaboration with healthcare experts reinforces its commitment to advancing healthcare for women globally. Hologic Inc's mission is to make a difference in people's lives through advanced healthcare solutions, making them a trusted and reliable leader in the industry.
Analytici aktuálne stanovujú priemernú cieľovú cenu 76,66 USD pre akciu Hologic (medián: 77,52 USD), teda +0,9 % voči poslednej cene. Konsenzus vychádza z 23 hodnotení.
23 analytikov aktuálne hodnotí akciu Hologic: 0 odporúča kúpiť, 20 držať a 3 predať. Na 2026 analytici očakávajú, že Hologic dosiahne tržby 4,24 Miliarda USD a zisk na akciu 4,49 USD.
Pri aktuálnom kurze sa akcia Hologic obchoduje za 69,23 EUR (76,01 USD).
Akcia Hologic (HOLX) je kótovaná na 9 burzách, okrem iného: NASDAQ (HOLX), London (0J5Q.L), SIX (Zürich) (HO1.SW), XETRA (HO1.DE), Frankfurt (HO1.F), München (HO1.MU), Düsseldorf (HO1.DU), Wien (HOLX.VI).
Hologic Inc is an international leading provider of medical technology products and solutions. The company, headquartered in Marlborough, Massachusetts, operates globally and is divided into four business segments: Diagnostics, Gynecology, Skeletal Health, and Aesthetics.
Tržby očakávané od Hologic sú 4,24 Miliarda USD. Táto hodnota je založená na aktuálnych finančných údajoch a odráža obchodnú výkonnosť spoločnosti.
Zisk očakávané od Hologic je 1,01 Miliarda USD. Čistý zisk odráža ziskovosť spoločnosti po odpočítaní všetkých nákladov.
Pomer ceny k zisku (P/E) Hologic je v súčasnosti 16,93. P/E pomer porovnáva aktuálnu cenu akcie s ziskom na akciu a pomáha investorom pochopiť ocenenie akcie Hologic.
Pomer ceny k tržbám (P/S) Hologic je v súčasnosti 4,05. P/S pomer porovnáva tržnú kapitalizáciu s ročnými tržbami a slúži ako metryka ocenenia akcie Hologic.
Skóre kvality AlleAktien pre Hologic je 1/10.
ISIN Hologic je US4364401012. ISIN (Medzinárodné číslo identifikácie cenného papiera) je globálne jedinečný identifikátor cenných papierov.
WKN Hologic je 879100. WKN (Wertpapierkennnummer) je šesťmiestny nemecký identifikačný kód cenného papiera.
Ticker Hologic je HOLX. Tento burzovný symbol sa používa na obchodovanie akcií Hologic na burze.
Hologic akcia
Hologic Peer Group
Hologic Ticker
Hologic FIGI
Ďalšie kľúčové údaje a analýzy Hologic v podrobnom prieskume
Naša analýza akcií spoločnosti Hologic obsahuje dôležité finančné ukazovatele, ako sú tržby, zisk, P/E pomer, P/S pomer, EBIT, ako aj informácie o dividende. Okrem toho skúmame aspekty, ako sú akcie, trhová kapitalizácia, dlhy, vlastné imanie a záväzky spoločnosti Hologic. Ak hľadáte podrobnejšie informácie k týmto témam, na našich podstránkach vám ponúkame podrobné analýzy: